Reducing hydrophobicity of homogeneous antibody-drug sorted by
relevance

Admin10.10.2021

Reducing hydrophobicity of homogeneous antibody-drug

9004
Admin20.09.2021

Reducing hydrophobicity of homogeneous antibody-drug

6206
Admin16.08.2021

Reducing hydrophobicity of homogeneous antibody-drug

3808
Admin23.08.2021

Reducing hydrophobicity of homogeneous antibody-drug

6907
Admin24.09.2021

Reducing hydrophobicity of homogeneous antibody-drug

7204
Admin02.10.2021

Alteration of Physicochemical Properties for Antibody-Drug

1505
Admin12.09.2021

Alteration of Physicochemical Properties for Antibody-Drug

9204
Admin16.08.2021

(PDF) Hydrophilic Auristatin Glycoside Payload Enables

3209
Admin31.08.2021

(PDF) Hydrophilic Auristatin Glycoside Payload Enables

8809
Admin05.08.2021

Characteristaion of individual DAR 1 to 4 variants by (A

2205
Admin04.10.2021

WO2011156328A1 - Cysteine engineered antibodies and

7202
Admin25.09.2021

WO2008141044A2 - Cysteine engineered anti-muc16 antibodies

107
Admin09.08.2021

Structure/function analysis of spinalin, a spine protein

4409
Admin21.07.2021

ELISA Microplates | Microplates for Drug Discovery | Corning

9806
Admin29.08.2021

MTT assay: Cell viability assay by MTT shows reduction in

2502
Admin14.07.2021

MTT assay: Cell viability assay by MTT shows reduction in

1004
Admin12.08.2021

MTT assay: Cell viability assay by MTT shows reduction in

Admin02.09.2021

Toxins | Free Full-Text | Immunotoxins and Anticancer Drug

3601
Admin16.09.2021

Strategies and Advancement in Antibody-Drug Conjugate

2308
Admin17.07.2021

TEM images of A) stained SVLP and B) purified SVLP-QDs

3005
Admin24.07.2021

How to Select the Best Blocking Reagents for CLIAs

4608